MedPath

ETODOLAC

ETODOLAC TABLETS 400 MG

Approved
Approval ID

b17228a1-38c3-4fa3-a83d-0654f18edabc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 3, 2012

Manufacturers
FDA

STAT Rx USA LLC

DUNS: 786036330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ETODOLAC

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42549-511
Application NumberANDA076004
Product Classification
M
Marketing Category
C73584
G
Generic Name
ETODOLAC
Product Specifications
Route of AdministrationORAL
Effective DateApril 3, 2012
FDA Product Classification

INGREDIENTS (8)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
METHYLCELLULOSE (100 CPS)Inactive
Code: 4GFU244C4J
Classification: IACT
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT
HYDROXYPROPYL CELLULOSEInactive
Code: RFW2ET671P
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
ETODOLACActive
Quantity: 400 mg in 1 1
Code: 2M36281008
Classification: ACTIB
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1A
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ETODOLAC - FDA Drug Approval Details